Skip to main content
Premium Trial:

Request an Annual Quote

U of Queensland Adds Nine ABI SOLiD Systems

NEW YORK (GenomeWeb News) – Researchers at the University of Queensland will add nine new sequencing systems from Applied Biosystems to its labs in order to support its efforts in the International Cancer Genome Consortium.

The university's Institute for Molecular Bioscience (IMB) will acquire the nine ABI SOLiD Systems, bringing its total owned to 11, which it will use in its studies focused on pancreatic and ovarian cancer in Australia.

The company will provide service and support for the systems, as well as bioinformatic analytical support for understanding and identifying genetic variations in the tumors. IMB will use the systems to sequence and map genetic changes that occur in these cancers, which can lead to uncontrolled growth.

Sean Grimmond, who is IMB's leader of the genomics and computational group, said in a statement that the system will "enable us to conduct complete genomic surveys of cancerous tumors and better understand the factors, including structural variants and single nucleotide polymorphisms, which are promoting uncontrolled growth within the tumor.

"By discovering the genes that are the key suspects in driving a cancer, we can begin to develop targeted drug therapies," he added.

Financial terms of the agreement were not released.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.